Clinical trial
Topical 5% Imiquimod Cream for Vulvar Paget's Disease
NCT02385188 · University Medical Center Nijmegen, Other · Completed
Key facts
| NCT number | NCT02385188 |
|---|---|
| Title | Topical 5% Imiquimod Cream for Vulvar Paget's Disease |
| Official title | Topical 5% Imiquimod Cream for Vulvar Paget's Disease: Clinical Efficacy, Safety and Immunological Response |
| Lead sponsor | University Medical Center Nijmegen, Other |
| Collaborators | Leiden University Medical Center University Medical Center Groningen Erasmus Medical Center The Netherlands Cancer Institute UMC Utrecht Catharina Ziekenhuis Eindhoven |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Paget Disease, Extramammary |
| Intervention type | Drug |
| Interventions | Imiquimod, paracetamol, lidocaine in Vaseline ointment |
| Enrollment | 25 |
| Start date | May 1, 2015 |
| Primary completion | Mar 1, 2018 |
| Completion | Nov 1, 2019 |
| First posted | Mar 11, 2015 |
| Last update posted | Jan 2, 2020 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: